Ilenia Pellarin
Aviano, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
CDK12/13 inhibition overcomes platinum resistance by impairing RNA metabolism.
Journal: Signal transduction and targeted therapy
Published: January 20, 2026
USP1 deubiquitinates PARP1 to regulate its trapping and PARylation activity.
Journal: Science advances
Published: November 13, 2024
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease.
Journal: Signal transduction and targeted therapy
Published: June 20, 2024
Insights into the structural and functional activities of forgotten Kinases: PCTAIREs CDKs.
Journal: Molecular cancer
Published: February 21, 2024
Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer.
Journal: EMBO molecular medicine
Published: July 03, 2023
Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulation.
Journal: Cancer communications (London, England)
Published: December 12, 2022
HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel.
Journal: Cell death & disease
Published: August 18, 2021
RNA splicing alteration in the response to platinum chemotherapy in ovarian cancer: A possible biomarker and therapeutic target.
Journal: Medicinal research reviews
Published: June 17, 2020
miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC.
Journal: EMBO molecular medicine
Published: June 04, 2020
Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells.
Journal: Oncogene
Published: December 30, 2019
Last Updated: 09/26/2026